Evidence map›Paper›PMID 22905168›Full record

ArticlePloS one2012

n-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1.

Tsung-Hua Hsieh, Cheng-Fang Tsai, Chia-Yi Hsu, Po-Lin Kuo, Edward Hsi, Jau-Ling Suen, Chih-Hsing Hung, Jau-Nan Lee, Chee-Yin Chai, Shao-Chun Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Endocrine-disrupting compounds and metabolomic reprogramming in breast cancer.Journal of biochemical and molecular toxicology · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. HDAC inhibitors target HDAC5, upregulate microRNA-125a-5p, and induce apoptosis in breast cancer cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Tsung-Hua HsiehGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Cheng-Fang Tsai
Chia-Yi Hsu
Po-Lin Kuo
Edward Hsi
Jau-Ling Suen
Chih-Hsing Hung
Jau-Nan Lee
Chee-Yin Chai
Shao-Chun Wang
Eing-Mei Tsai
Kaohsiung Medical University · TWUniversity of Cincinnati Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmental hormones play important roles in regulating the expression of genes involved in cell proliferation, drug resistance, and breast cancer risk; however, their precise role in human breast cancer cells during cancer progression remains unclear. To elucidate the effect of the most widely used industrial phthalate, n-butyl benzyl phthalate (BBP), on cancer progression, we evaluated the results of BBP treatment using a whole human genome cDNA microarray and MetaCore software and selected candidate genes whose expression was changed by more than ten-fold by BBP compared with controls to analyze the signaling pathways in human breast cancer initiating cells (R2d). A total of 473 genes were upregulated, and 468 were downregulated. Most of these genes are involved in proliferation, epithelial-mesenchymal transition, and angiogenesis signaling. BBP induced the viability, invasion and migration, and tube formation in vitro, and Matrigel plug angiogenesis in vivo of R2d and MCF-7. Furthermore, the viability and invasion and migration of these cell lines following BBP treatment was reduced by transfection with a small interfering RNA targeting the mRNA for lymphoid enhancer-binding factor 1; notably, the altered expression of this gene consistently differentiated tumors expressing genes involved in proliferation, epithelial-mesenchymal transition, and angiogenesis. These findings contribute to our understanding of the molecular impact of the environmental hormone BBP and suggest possible strategies for preventing and treating human breast cancer.

Indexed as

Gene Expression Regulation, NeoplasticBreast NeoplasmsCell Line, TumorCell SurvivalDisease ProgressionDNA, ComplementaryFemaleFlow CytometryGenome, HumanHumansLymphoid Enhancer-Binding Factor 1Oligonucleotide Array Sequence AnalysisPhthalic AcidsRNASignal TransductionTetrazolium Salts2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxidebutylbenzyl phthalateDNA, ComplementaryLEF1 protein, humanLymphoid Enhancer-Binding Factor 1Phthalic AcidsRNATetrazolium Salts

Identifiers

PMID22905168
PMCPMC3414447
OpenAlexW1986682393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.